Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
Taiho Oncology, Inc.
NRG Oncology
Eli Lilly and Company
Hoffmann-La Roche
BioNTech SE
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Prestige Biopharma Limited
Avistone Biotechnology Co., Ltd.
Checkpoint Therapeutics, Inc.
Novartis
Samsung Bioepis Co., Ltd.
EpicentRx, Inc.
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
Ionis Pharmaceuticals, Inc.
Radiation Therapy Oncology Group
Eli Lilly and Company
Wake Forest University Health Sciences
University of Turin, Italy
CTI BioPharma
CTI BioPharma
Celgene
Jiangsu HengRui Medicine Co., Ltd.
Bristol-Myers Squibb
Incyte Corporation
Institut Cancerologie de l'Ouest
Alliance for Clinical Trials in Oncology
Novartis
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Martha-Maria Krankenhaus Halle-Dölau gGmbH
University College, London
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)